Drug Shortage Report for ONIVYDE
Report ID | 28908 |
Drug Identification Number | 02467135 |
Brand name | ONIVYDE |
Common or Proper name | Irinotecan Liposome for Injection |
Company Name | IPSEN BIOPHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | IRINOTECAN HYDROCHLORIDE |
Strength(s) | 43MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAVENOUS |
Packaging size | Vials of 43g/10ML |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2017-11-07 |
Actual start date | 2017-11-08 |
Estimated end date | 2017-12-11 |
Actual end date | 2017-12-06 |
Shortage status | Resolved |
Updated date | 2017-12-07 |
Company comments | For emergency supply, please contact Baxalta customer service at +1 844 423 2090. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5050 SATELLITE DRIVE MISSISSAUGA, ONTARIO CANADA L4W 0G1 |
Company contact information | medinfoandsafetycanada@ipsen.com 1(855) 215-2288 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-12-07 | English | Compare |
v6 | 2017-12-06 | French | Compare |
v5 | 2017-12-06 | English | Compare |
v4 | 2017-11-10 | French | Compare |
v3 | 2017-11-10 | French | Compare |
v2 | 2017-11-10 | English | Compare |
v1 | 2017-11-10 | English | Compare |
Showing 1 to 7 of 7